Evolent Health (EVH) Capital Expenditures (2015 - 2026)

Evolent Health has reported Capital Expenditures for 12 years, with the latest figure at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 25.47% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 13.35% YoY), and the FY2025 full-year result was $34.1 million, up 36.94% from the prior year.
• Capital Expenditures for Q1 2026 stood at $6.4 million, down from $7.8 million in the prior quarter.
• The five-year high for Capital Expenditures was $10.7 million in Q4 2022, with the low at $5.3 million in Q1 2024.
• Average Capital Expenditures over 5 years is $7.8 million, with a median of $7.8 million recorded in 2025.
• Year-over-year, Capital Expenditures soared 65.79% in 2022 and slumped 43.67% in 2023.
• Tracing EVH's Capital Expenditures over 5 years: stood at $10.7 million in 2022, then tumbled by 43.67% to $6.1 million in 2023, then increased by 1.64% to $6.2 million in 2024, then grew by 26.17% to $7.8 million in 2025, then retreated by 17.46% to $6.4 million in 2026.
• The last three Capital Expenditures figures came in at $6.4 million (Q1 2026), $7.8 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.

Peer Comparison